Recent Finacing
Recent Raise
Neucore Bio engineers fibroblast-derived extracellular vesicles (FiXE™) as non-viral exosome carriers for RNA therapeutics, targeting specific cell types (e.g., Schwann cells) and conducting preclinical optimization and co-culture validation.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
